Arvelle Therapeutics - Angelini Pharma Company Revenue and Competitors

License our Company Data API

Zug,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

Arvelle Therapeutics - Angelini Pharma Company's estimated annual revenue is currently $6.2M per year.(i)
Arvelle Therapeutics - Angelini Pharma Company's estimated revenue per employee is $155,000

Employee Data

Arvelle Therapeutics - Angelini Pharma Company has 40 Employees.(i)
Arvelle Therapeutics - Angelini Pharma Company grew their employee count by -69% last year.

Arvelle Therapeutics - Angelini Pharma Company's People

Name	Title	Email/Phone

Arvelle Therapeutics - Angelini Pharma Company Competitors & AlternativesAdd Company

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$81.4M	375	40%	N/A	N/A
#2 Metrum Research...	$16.9M	109	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	120	-70%	$145M	N/A
#4 ArcherDX	$2.9M	37	-24%	$150M	N/A
#5 Inscripta	$1.3M	17	0%	$459.5M	N/A
#6 Cerapedics	$49.2M	254	15%	$180.7M	N/A
#7 Stone Clinical ...	$7M	45	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	840	9%	$168.5M	N/A
#9 CreoSalus	$4.2M	27	-7%	N/A	N/A
#10 MSBiotec	$10.1M	65	5%	N/A	N/A

Add Company

Show More Biotech Companies

What Is Arvelle Therapeutics - Angelini Pharma Company?

Arvelle is an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. At Arvelle we are committed to helping the millions of patients who are affected by CNS disorders. We aspire to do this by making innovative therapies available to more patients.

keywords:N/A

N/A

Total Funding

Number of Employees

$6.2M

Revenue (est)

-69%

Employee Growth %

N/A

Valuation

N/A

Accelerator